In the BioHarmony Drug Report Database

"Preview" Icon

Valganciclovir

Valcyte (valganciclovir) is a small molecule pharmaceutical. Valganciclovir was first approved as Valcyte on 2001-03-29. It is used to treat aids-related opportunistic infections, cytomegalovirus infections, and cytomegalovirus retinitis in the USA. Valcyte’s patent is valid until 2027-12-11 (FDA).

 

Trade Name

 

Valcyte
 

Common Name

 

valganciclovir
 

ChEMBL ID

 

CHEMBL1201314
 

Indication

 

aids-related opportunistic infections, cytomegalovirus infections, cytomegalovirus retinitis
 

Drug Class

 

Antivirals: antivirals (acyclovir type)

Image (chem structure or protein)

Valganciclovir structure rendering